Abstract
Various forms of marihuana preparations have been used and abused for nearly 5,000 years (Rossi, 1970). However, precise systematic delineation of toxicologic and pharmacologic effects has only been possible since the recent isolation and identification of delta-9-tetrahydrocannabinol (delta-9-THC) as the major active component (Gaoni and Mechoulam, 1964), and delta-8-THC as a minor active constituent in cannabis (Hively, Mosher and Hoffman, 1966). The signs of acute toxicity produced by these cannabinoids in rats, dogs, and monkeys included severe hypothermia, bradypnea, rapid weight loss, ataxia, muscle tremors, prostration, and hyperreactivity to stimuli (Thompson, Rosenkrantz, Schaeppi and Braude, 1973). In addition, dogs and monkeys exhibited salivation, emesis, and drowsiness. Rats treated chronically with cannabinoids developed tolerance to most signs of depression and, ultimately, exhibited increased activity and convulsions (Thompson, Mason, Rosenkrantz and Braude, 1974). These cannabinoids, therefore, produced similar signs of toxicity in various species, but some species differences were apparent.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gaoni, V. & Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Amer. Chem. Soc. (1964), 86, 1646–1648.
Hively, R.L., Mosher, W.A., & Hoffman, F. Isolation of trans-delta-6-tetrahydrocannabinol from marihuana. J. Amer. Chem. Soc. (1966), 88, 1832–1833.
Ho, B.T., Taylor, D., Englert, L.F., & McIsaac, W.M. Neurochemical effects of L-delta-9-tetrahydrocannabinol in rats following repeated inhalation. Brain Res. (1971), 31, 233–236.
Litchfield, J.T. & Wilcoxon, F. A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. (1949), 96, 99–113.
Luthra, Y.K. & Rosenkrantz, R. Cannabinoids: Neurochemical aspects after oral chronic administration to rats. Tox. Appl. Pharmacol. (1974), 27, 158–168.
Rossi, G.V. Pharmacological effects of drugs that are abused. Amer. J. Pharm. (1970), 142, 161–170.
Thompson, G.R., Fleischman, R.W., Rosenkrantz, R., & Braude, M.C. Oral and intravenous toxicity of delta-9-tetrahydrocannabinol in rhesus monkeys. Tox. Appl. Pharmacol. (1974), 27, 648–665.
Thompson, G.R., Mason, M.M., Rosenkrantz, R., & Braude, M.C. Chronic oral toxicity of cannabinoids in rats. Tox. Appl. Pharmacol. (1973), 25, 373–390.
Thompson, G.R., Rosenkrantz, R., Fleischman, R.W., & Braude, M.C. Effects of delta-9-tetrahydrocannabinol administered subcutaneously to rabbits for 28 days. Toxicology (1975), 4, 41–51.
Thompson, G.R., Rosenkrantz, R., Schaeppi, U.H., & Braude, M.C. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. Tox. Appl. Pharmacol. (1973), 25, 363–372.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Publishing Corporation
About this chapter
Cite this chapter
Thompson, G.R., Yang, C.L. (1976). Comparative Toxicities of Tetrahydropyridobenzopyrans. In: Cohen, S., Stillman, R.C. (eds) The Therapeutic Potential Of Marihuana. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4286-1_33
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4286-1_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4288-5
Online ISBN: 978-1-4613-4286-1
eBook Packages: Springer Book Archive